Shepherd Kaplan Krochuk’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Shepherd Kaplan Krochuk’s Portfolio FLXN Stock Details FLXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-11,428	Closed	-$276K	–	274
2017 Q3	$276K	Hold	11,428	–	–	0.23%	127
2017 Q2	$231K	Hold	11,428	–	–	0.13%	153
2017 Q1	$308K	Sell	11,428 -4,004	-26%	-$81.7K	0.16%	125
2016 Q4	$294K	Sell	15,432 -26,323	-63%	-$503K	0.08%	132
2016 Q3	$816K	Hold	41,755	–	–	0.17%	73
2016 Q2	$625K	Buy	+41,755	New	+$525K	0.16%	88
2015 Q2	–	Sell	-14,378	Closed	-$324K	–	461
2015 Q1	$324K	Buy	+14,378	New	+$333K	0.06%	226

Other funds holding FLXN

GGHC

Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Shepherd Kaplan Krochuk's FLXN Position: Q4 2017 in Review

Shepherd Kaplan Krochuk sold out of Flexion Therapeutics, Inc. (FLXN) in Q4 2017, closing a stake of 11,428 shares — an estimated $276K sold.

Shepherd Kaplan Krochuk first reported a position in FLXN in Q1 2015 and held it in 7 quarters. The position peaked at $816K in Q3 2016. 139 funds tracked by Wall St. Rank hold FLXN as of Q4 2017.

Shepherd Kaplan Krochuk reported no remaining Flexion Therapeutics, Inc. position as of Q4 2017 after selling out during the quarter.
Shepherd Kaplan Krochuk sold 11,428 Flexion Therapeutics, Inc. shares in Q4 2017, an estimated $276K.
Shepherd Kaplan Krochuk first reported a position in Flexion Therapeutics, Inc. in Q1 2015 and held it in 7 quarters.
Shepherd Kaplan Krochuk's Flexion Therapeutics, Inc. position peaked at $816K in Q3 2016.
139 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2017.

Based on Shepherd Kaplan Krochuk's 13F filing for Q4 2017, filed 13 Feb 2018.